Back to Journals » Patient Preference and Adherence » Volume 7

User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study [Corrigendum]

Authors Tauber M, Jaquet D, Jesuran-Perelroizen M, Petrus M, Bertrand AM, Coutant R

Received 25 June 2013

Accepted for publication 25 June 2013

Published 19 August 2013 Volume 2013:7 Pages 803—804

DOI https://doi.org/10.2147/PPA.S50485


Tauber M, Jaquet D, Jesuran-Perelroizen M, Petrus M, Bertrand AM, Coutant R. Patient Preference and Adherence. 2013;7:455–462.
On pages 455; 456; 458 and 459 NordiFlex manufacturer’s details were incorrectly listed as "Novo Nordisk, Princeton, NY, USA". The correct manufacturer’s details are "Novo Nordisk A/S, Bagsværd, Denmark".

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]